Scancell (LON:SCLP) Share Price Breaks Below 200 Day Moving Average – Time to Sell?

Shares of Scancell Holdings plc (LON:SCLP) crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of GBX 13.87 and traded as low as GBX 9.30. Scancell shares last traded at GBX 9.30, with a volume of 278,709 shares.

Scancell Stock Down 0.5%

The company has a current ratio of 0.28, a quick ratio of 13.01 and a debt-to-equity ratio of -88.01. The firm has a market capitalization of £126.17 million, a PE ratio of -16.91 and a beta of 0.69. The firm has a 50-day moving average of GBX 9.63 and a two-hundred day moving average of GBX 13.87.

Scancell (LON:SCLP) last issued its earnings results on Friday, October 9th. The company reported GBX (1.73) earnings per share for the quarter. Scancell had a negative net margin of 116.98% and a positive return on equity of 128.87%. On average, equities research analysts forecast that Scancell Holdings plc will post -2.54 EPS for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage company leveraging two proprietary platforms, Immunobody® and Moditope®, to develop targeted off-the-shelf, patient-accessible active immunotherapies for a cancer-free future. The lead product iSCIB1+ is an Immunobody® DNA active immunotherapy that has demonstrated monotherapy activity in adjuvant melanoma. When combined with checkpoint therapies it showed additional clinical benefit over the checkpoints (CPI) alone in the ongoing Phase 2 SCOPE trial in advanced melanoma.